Digital Therapeutics Market Share, Size, Trends - [2022-2027]

1
Request Sample
2
Digital Therapeutics (DTx) Market worth 17.7
billion by 2027
MARKET OPPORTUNITY OVER NEXT 5 YEARS
TWO OF THE KEY DRIVERS OF THE MARKET WILL BE
KEY MARKET PLAYERS
CAGR of 31.6
2022-2027

• Noom, Inc (US)
• Teladoc Health, Inc. (US)
• Omada Health, Inc. (US)

CAGR

• Need to control healthcare costs

North America commanded the largest share of the
digital therapeutics market
Market Segmentation by Equipment category

• By application, treatment/care-related
  applications form the largest segment of the
  digital therapeutics market
• The B2B segment is the largest and
  fastest-growing segment of the market during the
  forecast period.

Growth in this market is primarily driven by the
government initiatives to support technological
developments, and advancements in the field of
digital therapeutics to curb growing healthcare
costs.

3
Medical Device Reprocessing Market worth 3.9
billion by 2027
The report "Digital Therapeutics (DTx) Market by
Application (Prediabetes, Nutrition, Care,
Diabetes, CVD, CNS, CRD, MSD, GI, Substance
Abuse, Rehabilitation), Sales Channel B2C
(Patient, Caregiver), B2B ( Providers, Payer,
Employer, Pharma) - Global Forecasts to 2027", is
projected to reach USD 17.7 billion by 2027 from
USD 4.5 billion in 2022, at a CAGR of
31.6. Browse 190 market data Tables and 33
Figures spread through 231 Pages and in-depth TOC
on "Digital Therapeutics (DTx) Market by
Application (Prediabetes, Nutrition, Care,
Diabetes, CVD, CNS, CRD, MSD, GI, Substance
Abuse, Rehabilitation), Sales Channel B2C
(Patient, Caregiver), B2B ( Providers, Payer,
Employer, Pharma) - Global Forecasts to
2027 View detailed Table of Content
here - https//www.marketsandmarkets.com/Market-Re
ports/digital-therapeutics-market-51646724.html
4
Medical Device Reprocessing Market worth 3.9
billion by 2027
The digital therapeutics market is mainly driven
by factors such as increasing investments in
digital therapeutics, rising incidence of
preventable chronic diseases, increasing
government initiatives to support technological
developments, and developments in the field of
digital therapeutics to curb growing healthcare
costs. However, hesitancy among patients to adopt
digital therapeutics, and uneven payment models
are challenging the growth of this
market. Treatment/care-related applications
segment is expected to account for the largest
share of the digital therapeutics market in
2022 Based on application digital therapeutics
market is segmented into preventive and
treatment/care-related applications. The
treatment/care-related applications segment is
expected to hold the largest share of this market
in 2022. The growth of this segment is primarily
attributed to the increasing healthcare costs,
the rising prevalence of chronic diseases, and
the ability of digital therapeutics to deliver
cost-effective solutions.
5
Medical Device Reprocessing Market worth 3.9
billion by 2027
B2B segment is estimated to account for the
largest share of the digital therapeutics
market Based on sales channel, digital
therapeutics market is segmented into
business-to-customer (B2C) and business-to-busines
s (B2B). The B2B segment is estimated to account
for the largest share of the digital therapeutics
market in 2022. Factors such as increasing
partnership between many leading digital
therapeutics provider companies and payers,
providers, and employers to enhance their
customer base are driving the B2B sales of
digital therapeutics solutions. North America is
expected to hold the largest share of the digital
therapeutics market in 2022 The digital
therapeutics market has been segmented into four
main regional segments North America, Europe,
the Asia Pacific, and Rest of the World. North
America is expected to hold the largest share of
this market, followed by Europe in 2022. The
market in North America is also expected to grow
at the highest CAGR. The large share can be
attributed to the rising number of new start-ups
in digital therapeutics market and slowly
developing reimbursement structures for digital
therapeutics solutions.
6
Medical Device Reprocessing Market worth 3.9
billion by 2027
Prominent players in the digital therapeutics
market include Noom, Inc (US), Teladoc Health,
Inc. (US), Omada Health, Inc. (US), WellDoc, Inc
(US), Pear Therapeutics, Inc. (US), CogniFit Inc
(US), Ginger (US), Propeller Health (US),
2Morrow, Inc. (US), Canary Health (US), Click
Therapeutics, Inc. (US), Akili, Inc. (US),
Cognoa, Inc (US), Wellthy Therapeutics Pvt. Ltd.
(India), Twill Inc. (US), Better Therapeutics,
Inc (US), Mindstrong (US), Kaia Health (Germany),
BehaVR Inc (US), Ayogo (Canada), Mindable Health
GmbH (Germany), Virta Health Corp (US), Hinge
Health, Inc. (US), Orexo AB (Sweden) and
Freespira (US). Dont miss out on business
opportunities in Digital Therapeutics (DTx)
Market. Speak to our analyst and gain crucial
industry insights that will help your business
grow.
7
About MarketsandMarkets
MarketsandMarkets provides quantified B2B
research on 30,000 high growth niche
opportunities/threats which will impact 70 to
80 of worldwide companies revenues. Currently
servicing 7500 customers worldwide including 80
of global Fortune 1000 companies as clients.
Almost 75,000 top officers across eight
industries worldwide approach MarketsandMarkets
for their painpoints around revenues
decisions. Our 850 fulltime analyst and SMEs at
MarketsandMarkets are tracking global high
growth markets following the "Growth Engagement
Model GEM". The GEM aims at proactive
collaboration with the clients to identify new
opportunities, identify most important customers,
write "Attack, avoid and defend" strategies,
identify sources of incremental revenues for both
the company and its competitors.
MarketsandMarkets now coming up with 1,500
MicroQuadrants (Positioning top players across
leaders, emerging companies, innovators,
strategic players) annually in high growth
emerging segments. MarketsandMarkets is
determined to benefit more than 10,000 companies
this year for their revenue planning and help
them take their innovations/disruptions early to
the market by providing them research ahead of
the curve. MarketsandMarketss flagship
competitive intelligence and market research
platform, "Knowledgestore" connects over 200,000
markets and entire value chains for deeper
understanding of the unmet insights along with
market sizing and forecasts of niche markets.
8
Contact
Mr. Aashish Mehra MarketsandMarkets INC. 630
Dundee Road Suite 430 Northbrook, IL 60062 USA
1-888-600-6441 sales_at_marketsandmarkets.com